Review





Similar Products

94
Guangzhou JET Bio-Filtration human opg (osteoprotegerin) elisa kit
Human Opg (Osteoprotegerin) Elisa Kit, supplied by Guangzhou JET Bio-Filtration, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human opg (osteoprotegerin) elisa kit/product/Guangzhou JET Bio-Filtration
Average 94 stars, based on 1 article reviews
human opg (osteoprotegerin) elisa kit - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

93
Multi Sciences (Lianke) Biotech Co Ltd human tr11b elisa kit multisciences cat
Human Tr11b Elisa Kit Multisciences Cat, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tr11b elisa kit multisciences cat/product/Multi Sciences (Lianke) Biotech Co Ltd
Average 93 stars, based on 1 article reviews
human tr11b elisa kit multisciences cat - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

94
Proteintech opg
COL-I, OCN, <t>OPG</t> and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; <t>OCN,</t> <t>osteocalcin;</t> OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
Opg, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/opg/product/Proteintech
Average 94 stars, based on 1 article reviews
opg - by Bioz Stars, 2026-02
94/100 stars
  Buy from Supplier

93
Cusabio opg elisa kit
Depletion of miR-185 in MLO-Y4 cells reduces the osteoclastogenic potential of RAW264.7 cells. ( A ) The levels of soluble RANKL (sRANKL) and osteoprotegerin <t>(OPG)</t> in the serum of WT and miR-185 KO mice were quantified by <t>ELISA</t> ( n = 3). ( B ) The concentrations of sRANKL and OPG in conditioned medium from WT and miR-185 KO MLO-Y4 cells were measured by ELISA ( n = 3). ( C ) RAW264.7 cells were co-cultured for 4 days with conditioned medium derived from miR-185 KO, sh Arl8b , and corresponding control MLO-Y4 cells, supplemented with 50 ng/mL RANKL and 30 ng/mL M-CSF ( n = 3). After 4 days of culture, qPCR was performed to evaluate mRNA expression levels of osteoclast marker genes, including Trap , DC-stamp , Ctsk , and Nfatc1 . ( D ) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained osteoclast cultures ( n = 3). ( E ) TRAP-positive cells were counted based on the number of nuclei. ( F ) TRAP-positive multinucleated cells (containing > 3 nuclei) were quantified. ( G ) Cathepsin K (CTSK), a marker of osteoclasts, was detected by western blotting ( n = 3). ( H ) The mRNA expression of matrix metalloproteinase 14 ( Mmp14 ) in MLO-Y4 cells was measured by RT-qPCR ( n = 3). ( I , J ) The protein levels of MMP14 in MLO-Y4 cells were evaluated by western blotting. ( K ) Quantitative analysis of MMP14 protein expression was performed using ImageJ software. ( L )The mRNA expression of Mmp14 in the femurs of mice was assessed by qPCR ( n = 3). Data represent at least three independent experiments and are shown as mean ± S.D. (ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001). The full-length blot is presented in supplementary Raw Western
Opg Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/opg elisa kit/product/Cusabio
Average 93 stars, based on 1 article reviews
opg elisa kit - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

opg  (Cusabio)
86
Cusabio opg
Depletion of miR-185 in MLO-Y4 cells reduces the osteoclastogenic potential of RAW264.7 cells. ( A ) The levels of soluble RANKL (sRANKL) and osteoprotegerin <t>(OPG)</t> in the serum of WT and miR-185 KO mice were quantified by <t>ELISA</t> ( n = 3). ( B ) The concentrations of sRANKL and OPG in conditioned medium from WT and miR-185 KO MLO-Y4 cells were measured by ELISA ( n = 3). ( C ) RAW264.7 cells were co-cultured for 4 days with conditioned medium derived from miR-185 KO, sh Arl8b , and corresponding control MLO-Y4 cells, supplemented with 50 ng/mL RANKL and 30 ng/mL M-CSF ( n = 3). After 4 days of culture, qPCR was performed to evaluate mRNA expression levels of osteoclast marker genes, including Trap , DC-stamp , Ctsk , and Nfatc1 . ( D ) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained osteoclast cultures ( n = 3). ( E ) TRAP-positive cells were counted based on the number of nuclei. ( F ) TRAP-positive multinucleated cells (containing > 3 nuclei) were quantified. ( G ) Cathepsin K (CTSK), a marker of osteoclasts, was detected by western blotting ( n = 3). ( H ) The mRNA expression of matrix metalloproteinase 14 ( Mmp14 ) in MLO-Y4 cells was measured by RT-qPCR ( n = 3). ( I , J ) The protein levels of MMP14 in MLO-Y4 cells were evaluated by western blotting. ( K ) Quantitative analysis of MMP14 protein expression was performed using ImageJ software. ( L )The mRNA expression of Mmp14 in the femurs of mice was assessed by qPCR ( n = 3). Data represent at least three independent experiments and are shown as mean ± S.D. (ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001). The full-length blot is presented in supplementary Raw Western
Opg, supplied by Cusabio, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/opg/product/Cusabio
Average 86 stars, based on 1 article reviews
opg - by Bioz Stars, 2026-02
86/100 stars
  Buy from Supplier

90
Elabscience Biotechnology human opg elisa kit
Depletion of miR-185 in MLO-Y4 cells reduces the osteoclastogenic potential of RAW264.7 cells. ( A ) The levels of soluble RANKL (sRANKL) and osteoprotegerin <t>(OPG)</t> in the serum of WT and miR-185 KO mice were quantified by <t>ELISA</t> ( n = 3). ( B ) The concentrations of sRANKL and OPG in conditioned medium from WT and miR-185 KO MLO-Y4 cells were measured by ELISA ( n = 3). ( C ) RAW264.7 cells were co-cultured for 4 days with conditioned medium derived from miR-185 KO, sh Arl8b , and corresponding control MLO-Y4 cells, supplemented with 50 ng/mL RANKL and 30 ng/mL M-CSF ( n = 3). After 4 days of culture, qPCR was performed to evaluate mRNA expression levels of osteoclast marker genes, including Trap , DC-stamp , Ctsk , and Nfatc1 . ( D ) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained osteoclast cultures ( n = 3). ( E ) TRAP-positive cells were counted based on the number of nuclei. ( F ) TRAP-positive multinucleated cells (containing > 3 nuclei) were quantified. ( G ) Cathepsin K (CTSK), a marker of osteoclasts, was detected by western blotting ( n = 3). ( H ) The mRNA expression of matrix metalloproteinase 14 ( Mmp14 ) in MLO-Y4 cells was measured by RT-qPCR ( n = 3). ( I , J ) The protein levels of MMP14 in MLO-Y4 cells were evaluated by western blotting. ( K ) Quantitative analysis of MMP14 protein expression was performed using ImageJ software. ( L )The mRNA expression of Mmp14 in the femurs of mice was assessed by qPCR ( n = 3). Data represent at least three independent experiments and are shown as mean ± S.D. (ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001). The full-length blot is presented in supplementary Raw Western
Human Opg Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human opg elisa kit/product/Elabscience Biotechnology
Average 90 stars, based on 1 article reviews
human opg elisa kit - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

93
Boster Bio opg
Depletion of miR-185 in MLO-Y4 cells reduces the osteoclastogenic potential of RAW264.7 cells. ( A ) The levels of soluble RANKL (sRANKL) and osteoprotegerin <t>(OPG)</t> in the serum of WT and miR-185 KO mice were quantified by <t>ELISA</t> ( n = 3). ( B ) The concentrations of sRANKL and OPG in conditioned medium from WT and miR-185 KO MLO-Y4 cells were measured by ELISA ( n = 3). ( C ) RAW264.7 cells were co-cultured for 4 days with conditioned medium derived from miR-185 KO, sh Arl8b , and corresponding control MLO-Y4 cells, supplemented with 50 ng/mL RANKL and 30 ng/mL M-CSF ( n = 3). After 4 days of culture, qPCR was performed to evaluate mRNA expression levels of osteoclast marker genes, including Trap , DC-stamp , Ctsk , and Nfatc1 . ( D ) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained osteoclast cultures ( n = 3). ( E ) TRAP-positive cells were counted based on the number of nuclei. ( F ) TRAP-positive multinucleated cells (containing > 3 nuclei) were quantified. ( G ) Cathepsin K (CTSK), a marker of osteoclasts, was detected by western blotting ( n = 3). ( H ) The mRNA expression of matrix metalloproteinase 14 ( Mmp14 ) in MLO-Y4 cells was measured by RT-qPCR ( n = 3). ( I , J ) The protein levels of MMP14 in MLO-Y4 cells were evaluated by western blotting. ( K ) Quantitative analysis of MMP14 protein expression was performed using ImageJ software. ( L )The mRNA expression of Mmp14 in the femurs of mice was assessed by qPCR ( n = 3). Data represent at least three independent experiments and are shown as mean ± S.D. (ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001). The full-length blot is presented in supplementary Raw Western
Opg, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/opg/product/Boster Bio
Average 93 stars, based on 1 article reviews
opg - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier

90
MyBiosource Biotechnology human opg and rankl elisa kits
Depletion of miR-185 in MLO-Y4 cells reduces the osteoclastogenic potential of RAW264.7 cells. ( A ) The levels of soluble RANKL (sRANKL) and osteoprotegerin <t>(OPG)</t> in the serum of WT and miR-185 KO mice were quantified by <t>ELISA</t> ( n = 3). ( B ) The concentrations of sRANKL and OPG in conditioned medium from WT and miR-185 KO MLO-Y4 cells were measured by ELISA ( n = 3). ( C ) RAW264.7 cells were co-cultured for 4 days with conditioned medium derived from miR-185 KO, sh Arl8b , and corresponding control MLO-Y4 cells, supplemented with 50 ng/mL RANKL and 30 ng/mL M-CSF ( n = 3). After 4 days of culture, qPCR was performed to evaluate mRNA expression levels of osteoclast marker genes, including Trap , DC-stamp , Ctsk , and Nfatc1 . ( D ) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained osteoclast cultures ( n = 3). ( E ) TRAP-positive cells were counted based on the number of nuclei. ( F ) TRAP-positive multinucleated cells (containing > 3 nuclei) were quantified. ( G ) Cathepsin K (CTSK), a marker of osteoclasts, was detected by western blotting ( n = 3). ( H ) The mRNA expression of matrix metalloproteinase 14 ( Mmp14 ) in MLO-Y4 cells was measured by RT-qPCR ( n = 3). ( I , J ) The protein levels of MMP14 in MLO-Y4 cells were evaluated by western blotting. ( K ) Quantitative analysis of MMP14 protein expression was performed using ImageJ software. ( L )The mRNA expression of Mmp14 in the femurs of mice was assessed by qPCR ( n = 3). Data represent at least three independent experiments and are shown as mean ± S.D. (ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001). The full-length blot is presented in supplementary Raw Western
Human Opg And Rankl Elisa Kits, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human opg and rankl elisa kits/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
human opg and rankl elisa kits - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


COL-I, OCN, OPG and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.

Journal: Molecular Medicine Reports

Article Title: Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis

doi: 10.3892/mmr.2025.13723

Figure Lengend Snippet: COL-I, OCN, OPG and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.

Article Snippet: The primary antibodies used and their dilution ratios are as follows: Type I collagen (COL-I; 1:200; cat. no. AF7001; Affinity Biosciences), osteocalcin (OCN, 1:200; cat. no. 16157-1-AP; Proteintech Group, Inc.) and OPG (1:200; cat. no 31766-1-AP; Proteintech Group, Inc.).

Techniques: Expressing, Control

mRNA expression levels of bone metabolism-related factors. *P<0.05 and ***P<0.01 vs. Ctrl group; ## P<0.01 vs. T2DM model group. (A) Ctrl, control; (B) T2DM, type 2 diabetes mellitus; (C) ZnC, zinc carnosine. OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand.

Journal: Molecular Medicine Reports

Article Title: Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis

doi: 10.3892/mmr.2025.13723

Figure Lengend Snippet: mRNA expression levels of bone metabolism-related factors. *P<0.05 and ***P<0.01 vs. Ctrl group; ## P<0.01 vs. T2DM model group. (A) Ctrl, control; (B) T2DM, type 2 diabetes mellitus; (C) ZnC, zinc carnosine. OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand.

Article Snippet: The primary antibodies used and their dilution ratios are as follows: Type I collagen (COL-I; 1:200; cat. no. AF7001; Affinity Biosciences), osteocalcin (OCN, 1:200; cat. no. 16157-1-AP; Proteintech Group, Inc.) and OPG (1:200; cat. no 31766-1-AP; Proteintech Group, Inc.).

Techniques: Expressing, Control

Depletion of miR-185 in MLO-Y4 cells reduces the osteoclastogenic potential of RAW264.7 cells. ( A ) The levels of soluble RANKL (sRANKL) and osteoprotegerin (OPG) in the serum of WT and miR-185 KO mice were quantified by ELISA ( n = 3). ( B ) The concentrations of sRANKL and OPG in conditioned medium from WT and miR-185 KO MLO-Y4 cells were measured by ELISA ( n = 3). ( C ) RAW264.7 cells were co-cultured for 4 days with conditioned medium derived from miR-185 KO, sh Arl8b , and corresponding control MLO-Y4 cells, supplemented with 50 ng/mL RANKL and 30 ng/mL M-CSF ( n = 3). After 4 days of culture, qPCR was performed to evaluate mRNA expression levels of osteoclast marker genes, including Trap , DC-stamp , Ctsk , and Nfatc1 . ( D ) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained osteoclast cultures ( n = 3). ( E ) TRAP-positive cells were counted based on the number of nuclei. ( F ) TRAP-positive multinucleated cells (containing > 3 nuclei) were quantified. ( G ) Cathepsin K (CTSK), a marker of osteoclasts, was detected by western blotting ( n = 3). ( H ) The mRNA expression of matrix metalloproteinase 14 ( Mmp14 ) in MLO-Y4 cells was measured by RT-qPCR ( n = 3). ( I , J ) The protein levels of MMP14 in MLO-Y4 cells were evaluated by western blotting. ( K ) Quantitative analysis of MMP14 protein expression was performed using ImageJ software. ( L )The mRNA expression of Mmp14 in the femurs of mice was assessed by qPCR ( n = 3). Data represent at least three independent experiments and are shown as mean ± S.D. (ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001). The full-length blot is presented in supplementary Raw Western

Journal: Stem Cell Research & Therapy

Article Title: Depletion of mmu-miR-185 enhances osteocyte connectivity and suppresses bone fragility through the interaction between ARL8B and RAB5A

doi: 10.1186/s13287-025-04612-y

Figure Lengend Snippet: Depletion of miR-185 in MLO-Y4 cells reduces the osteoclastogenic potential of RAW264.7 cells. ( A ) The levels of soluble RANKL (sRANKL) and osteoprotegerin (OPG) in the serum of WT and miR-185 KO mice were quantified by ELISA ( n = 3). ( B ) The concentrations of sRANKL and OPG in conditioned medium from WT and miR-185 KO MLO-Y4 cells were measured by ELISA ( n = 3). ( C ) RAW264.7 cells were co-cultured for 4 days with conditioned medium derived from miR-185 KO, sh Arl8b , and corresponding control MLO-Y4 cells, supplemented with 50 ng/mL RANKL and 30 ng/mL M-CSF ( n = 3). After 4 days of culture, qPCR was performed to evaluate mRNA expression levels of osteoclast marker genes, including Trap , DC-stamp , Ctsk , and Nfatc1 . ( D ) Representative images of tartrate-resistant acid phosphatase (TRAP)-stained osteoclast cultures ( n = 3). ( E ) TRAP-positive cells were counted based on the number of nuclei. ( F ) TRAP-positive multinucleated cells (containing > 3 nuclei) were quantified. ( G ) Cathepsin K (CTSK), a marker of osteoclasts, was detected by western blotting ( n = 3). ( H ) The mRNA expression of matrix metalloproteinase 14 ( Mmp14 ) in MLO-Y4 cells was measured by RT-qPCR ( n = 3). ( I , J ) The protein levels of MMP14 in MLO-Y4 cells were evaluated by western blotting. ( K ) Quantitative analysis of MMP14 protein expression was performed using ImageJ software. ( L )The mRNA expression of Mmp14 in the femurs of mice was assessed by qPCR ( n = 3). Data represent at least three independent experiments and are shown as mean ± S.D. (ns, not significant, * p < 0.05, ** p < 0.01, *** p < 0.001). The full-length blot is presented in supplementary Raw Western

Article Snippet: RANKL and OPG protein levels in the supernatants were determined using the sRANKL ELISA Kit (CUSABIO, cat# CSB-E05127m) and the OPG ELISA Kit (CUSABIO, cat# CSB-E04693m), respectively.

Techniques: Enzyme-linked Immunosorbent Assay, Cell Culture, Derivative Assay, Control, Expressing, Marker, Staining, Western Blot, Quantitative RT-PCR, Software